Is CVE-2026-41085 in the CISA KEV catalog?

No. CVE-2026-41085 is not currently on the CISA Known Exploited Vulnerabilities list.

What is the CVSS severity of CVE-2026-41085?

CVE-2026-41085 has a CVSS v3 base score of 8.8 (HIGH).

What is the EPSS score for CVE-2026-41085?

CVE-2026-41085 has an EPSS score of 0.26% (17th percentile), estimating the probability of exploitation in the next 30 days.

CVE & CISA-KEV Catalog

CVE-2026-41085

HIGH

8.8

CVSS v3

NVD

Description

Thermo Fisher Scientific Torrent Suite Dx through 5.14.2 has a privilege escalation vulnerability that may allow an authenticated user with limited access privileges to gain unauthorized administrator-level privileges through exploitation of specific system interfaces.

CWE-269Improper Privilege Management

CVSS v3 Vector

Exploitability

Attack VectorNetwork

Attack ComplexityLow

Privileges RequiredLow

User InteractionNone

ScopeUnchanged

Impact

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Exploit Intelligence

0.26%probability of exploitation in 30 days

17thpercentile

Low risk: more likely to be exploited than 17% of all known CVEs.

References

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2026-05-18.